+499.5%
MRNA vs INSM
-11.6%
+511.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | INSM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.3% | -1.9% | -2.1% |
| 7D | +5.5% | +6.5% | -1.1% | +3.6% |
| 30D | +158.7% | +27.5% | +131.2% | +146.9% |
| 3M | +182.1% | +20.4% | +161.8% | +173.9% |
| 6M | +151.8% | -15.7% | +167.6% | +169.0% |
| YTD | +393.6% | -27.4% | +421.0% | +455.3% |
| 1Y | +499.5% | -11.4% | +510.9% | +435.7% |
| All | +499.5% | -11.6% | +511.1% | +435.7% |
Cumulative growth
Daily Returns
Daily percentage return beside INSM.
Daily Out/Under-Performance
Portfolio return minus INSM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × INSM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded INSM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling